Quick answer
A peptide microneedle eye patch should be developed around compatibility, processing exposure, distribution, stability and cosmetic substantiation—not the peptide name alone.
Define the cosmetic purpose
Begin with appearance-oriented goals such as hydration, temporary smoothing or improved appearance of fine lines. Then identify peptide concepts that fit the intended market and evidence plan. An ingredient marketing story is not the same as a finished-product claim.
Compatibility questions
Review pH, ionic strength, oxidation sensitivity, water activity, interactions with the dissolvable polymer and other ingredients. The formula must still fill the array, dry predictably, release from the mold and maintain structural integrity.
Manage time, temperature and moisture
Low-temperature processing may reduce one form of stress, but longer time in a wet matrix can create another risk. Map total exposure during mixing, holding, filling, drying, handling and packaging. Define a drying endpoint rather than relying on a descriptive phrase.
Measure the right thing
Bulk formula content does not prove how much peptide is present in the projections. Depending on the project, analytical work may need to consider total content, purity, degradation, distribution, finished-patch sampling and stability. The method must be fit for the decision.
Package for the real shelf life
Moisture and oxygen protection can matter after manufacturing. Barrier structure, seal integrity, headspace, storage statement and secondary packaging should be evaluated for the actual finished pack.
Questions for the ODM partner
- Which peptide is being proposed and why?
- What process exposures are controlled?
- Which test is possible and what does it demonstrate?
- How will stability and package compatibility be assessed?
- Which cosmetic claims are proportionate to the evidence?